• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β受体阻滞剂、溶栓治疗及冠状动脉成形术对糖尿病合并冠状动脉疾病患者的疗效

Efficacy of beta blockade, thrombolytic therapy, and coronary angioplasty in diabetic patients with coronary artery disease.

作者信息

Simpfendorfer C

机构信息

Department of Cardiology, Cleveland Clinic Foundation, OH 44195.

出版信息

Cleve Clin J Med. 1993 Mar-Apr;60(2):145-9. doi: 10.3949/ccjm.60.2.145.

DOI:10.3949/ccjm.60.2.145
PMID:8095191
Abstract

Diabetes mellitus is an independent risk factor for coronary artery disease. In addition, ischemic heart disease is the major cause of mortality among diabetic patients. Early and late mortality after acute myocardial infarction is higher among diabetic patients. However, the effectiveness of newer treatments on diabetic patients with coronary artery disease has received little attention. This article reviews the effect of beta blockers and thrombolysis in diabetic patients after acute myocardial infarction and compares early and late results of percutaneous transluminal coronary angioplasty in diabetic patients with those in the nondiabetic population.

摘要

糖尿病是冠状动脉疾病的独立危险因素。此外,缺血性心脏病是糖尿病患者死亡的主要原因。糖尿病患者急性心肌梗死后的早期和晚期死亡率较高。然而,新型治疗方法对糖尿病冠状动脉疾病患者的有效性很少受到关注。本文综述了β受体阻滞剂和溶栓治疗对糖尿病患者急性心肌梗死后的影响,并比较了糖尿病患者与非糖尿病人群经皮腔内冠状动脉成形术的早期和晚期结果。

相似文献

1
Efficacy of beta blockade, thrombolytic therapy, and coronary angioplasty in diabetic patients with coronary artery disease.β受体阻滞剂、溶栓治疗及冠状动脉成形术对糖尿病合并冠状动脉疾病患者的疗效
Cleve Clin J Med. 1993 Mar-Apr;60(2):145-9. doi: 10.3949/ccjm.60.2.145.
2
Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group.糖尿病合并急性心肌梗死患者接受溶栓剂治疗的结果。心肌梗死溶栓与血管成形术(TAMI)研究组。
J Am Coll Cardiol. 1993 Mar 15;21(4):920-5. doi: 10.1016/0735-1097(93)90348-5.
3
Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.急性心肌梗死中直接冠状动脉血管成形术与静脉注射链激酶的比较:左心室射血分数、医院死亡率和再梗死情况。
J Am Coll Cardiol. 1994 Apr;23(5):1004-8. doi: 10.1016/0735-1097(94)90582-7.
4
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
Circulation. 2001 Feb 20;103(7):954-60. doi: 10.1161/01.cir.103.7.954.
5
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.糖尿病对急性心肌梗死溶栓时代临床结局的影响。GUSTO-I研究人员。链激酶和组织型纤溶酶原激活剂在闭塞冠状动脉中的全球应用。
J Am Coll Cardiol. 1997 Jul;30(1):171-9. doi: 10.1016/s0735-1097(97)00118-6.
6
Late outcome after percutaneous transluminal coronary angioplasty during acute myocardial infarction.
Am J Cardiol. 1993 Sep 15;72(9):634-9. doi: 10.1016/0002-9149(93)90876-e.
7
[Treatment of coronary heart disease in patients with diabetes mellitus].
Dtsch Med Wochenschr. 1998 Nov 20;123(47):1419-25. doi: 10.1055/s-2007-1024197.
8
Heart disease in diabetes mellitus.
Endocrinol Metab Clin North Am. 1996 Jun;25(2):425-38. doi: 10.1016/s0889-8529(05)70331-5.
9
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.急性心肌梗死接受溶栓治疗的糖尿病患者的血管造影结果及预后:全球应用链激酶和组织型纤溶酶原激活剂冠脉腔内溶栓(GUSTO-I)试验经验
J Am Coll Cardiol. 1996 Dec;28(7):1661-9. doi: 10.1016/s0735-1097(96)00397-x.
10
[Treatment of patients with ischemic heart disease and diabetes].
Medicina (Kaunas). 2004;40(2):192-7.

引用本文的文献

1
Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的使用与急性心肌梗死病情稳定的2型糖尿病患者心血管和肾脏结局的关联:一项倾向评分匹配研究
Front Cardiovasc Med. 2022 Apr 29;9:882181. doi: 10.3389/fcvm.2022.882181. eCollection 2022.
2
Atypical presentation of acute and chronic coronary artery disease in diabetics.糖尿病患者急性和慢性冠状动脉疾病的非典型表现。
World J Cardiol. 2014 Aug 26;6(8):802-13. doi: 10.4330/wjc.v6.i8.802.